| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12041-018-0953-5 |
| P698 | PubMed publication ID | 30027900 |
| P50 | author | B.K Thelma | Q64791484 |
| P2093 | author name string | Sanjay Pandey | |
| Sumeet Kumar | |||
| Navneesh Yadav | |||
| P2860 | cites work | Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease | Q21144949 |
| Huntington's disease: a clinical review | Q21202876 | ||
| Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease | Q22248076 | ||
| Variant of TREM2 Associated with the Risk of Alzheimer's Disease | Q22250874 | ||
| Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease | Q22251067 | ||
| A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline | Q22251083 | ||
| The genetic epidemiology of neurodegenerative disease | Q22306301 | ||
| Therapeutic interventions for disease progression in Huntington's disease | Q24239973 | ||
| Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS | Q24297462 | ||
| Huntingtin-associated protein-1 is a modifier of the age-at-onset of Huntington's disease | Q24306416 | ||
| Evidence of mutations in RIC3 acetylcholine receptor chaperone as a novel cause of autosomal-dominant Parkinson's disease with non-motor phenotypes. | Q53128059 | ||
| How heritable is Alzheimer's disease late in life? Findings from Swedish twins. | Q53259979 | ||
| High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. | Q53327610 | ||
| Investigation of TREM2, PLD3, and UNC5C variants in patients with Alzheimer's disease from mainland China. | Q53464960 | ||
| SnapShot: Genetics of ALS and FTD. | Q53617644 | ||
| Amyotrophic Lateral Sclerosis. | Q53750443 | ||
| Identification of a late onset Alzheimer's disease candidate risk variant at 9q21.33 in Polish patients. | Q54301341 | ||
| Genetic association study of PINK1 coding polymorphisms in Parkinson's disease. | Q54693465 | ||
| Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants | Q56769911 | ||
| LRRK2 gene in Parkinson disease: Mutation analysis and case control association study | Q57419082 | ||
| Collaborative Analysis of α-Synuclein Gene Promoter Variability and Parkinson Disease | Q57977634 | ||
| Association of Long ATXN2 CAG Repeat Sizes With Increased Risk of Amyotrophic Lateral Sclerosis | Q59314940 | ||
| Alzheimer's disease | Q60313667 | ||
| Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity | Q70142305 | ||
| APOE polymorphism in a rural older population-based sample in India | Q73827671 | ||
| Nitrosative and oxidative stress links dysfunctional ubiquitination to Parkinson's disease | Q81045087 | ||
| Genome screen of late-onset Alzheimer's extended pedigrees identifies TRPC4AP by haplotype analysis | Q81195554 | ||
| Parkin disease in a Brazilian kindred: Manifesting heterozygotes and clinical follow-up over 10 years | Q81248024 | ||
| Discovery of a frameshift mutation in podocalyxin-like (PODXL) gene, coding for a neural adhesion molecule, as causal for autosomal-recessive juvenile Parkinsonism | Q87265728 | ||
| Analysis of the UNC13A gene as a risk factor for sporadic amyotrophic lateral sclerosis | Q95806775 | ||
| Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism | Q24309753 | ||
| Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease | Q24312938 | ||
| ATF4 protects against neuronal death in cellular Parkinson's disease models by maintaining levels of parkin | Q24314995 | ||
| Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease | Q24316501 | ||
| Hereditary early-onset Parkinson's disease caused by mutations in PINK1 | Q24337084 | ||
| High-resolution whole-genome association study of Parkinson disease. | Q24535861 | ||
| Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease | Q24596763 | ||
| Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study | Q24600803 | ||
| Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies | Q24606055 | ||
| Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease | Q24610759 | ||
| Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease | Q24612662 | ||
| Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study | Q24622472 | ||
| De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes | Q24627067 | ||
| Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS | Q24633692 | ||
| GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers | Q24654145 | ||
| Genotypes at the GluR6 kainate receptor locus are associated with variation in the age of onset of Huntington disease | Q24685210 | ||
| Genotype-phenotype correlations of amyotrophic lateral sclerosis | Q26769063 | ||
| The genetic landscape of Alzheimer disease: clinical implications and perspectives | Q26796582 | ||
| Genetics of Parkinson's disease | Q26827825 | ||
| Deep brain stimulation: current status | Q26853163 | ||
| The role of the LRRK2 gene in Parkinsonism | Q27023749 | ||
| Huntington's disease: underlying molecular mechanisms and emerging concepts | Q27026255 | ||
| PARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease | Q27349225 | ||
| Mutation in the alpha-synuclein gene identified in families with Parkinson's disease | Q27860459 | ||
| A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. | Q27860836 | ||
| Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis | Q28131805 | ||
| Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease | Q28244731 | ||
| Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients | Q34397987 | ||
| Potential of ayurgenomics approach in complex trait research: leads from a pilot study on rheumatoid arthritis | Q34438363 | ||
| Genome-wide analysis correlates Ayurveda Prakriti | Q34499760 | ||
| Induced Pluripotent Stem Cells Meet Genome Editing | Q34525438 | ||
| Supportive and symptomatic management of amyotrophic lateral sclerosis | Q34537070 | ||
| Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans | Q34617467 | ||
| The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients | Q34873673 | ||
| Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis | Q35001476 | ||
| Systematic review of incidence studies of Parkinson's disease | Q35041286 | ||
| Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease | Q35084110 | ||
| The sydney multicentre study of Parkinson's disease: progression and mortality at 10 years | Q35452958 | ||
| Neurodegenerative processes in Huntington's disease | Q35572092 | ||
| Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study | Q35671414 | ||
| Heritability of Parkinson disease in Swedish twins: a longitudinal study | Q35675965 | ||
| Identification of novel loci for Alzheimer disease and replication of CLU, PICALM, and BIN1 in Caribbean Hispanic individuals | Q35712611 | ||
| SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population | Q35859538 | ||
| Identification of Genetic Factors that Modify Clinical Onset of Huntington's Disease | Q35915245 | ||
| Update on deep brain stimulation in Parkinson's disease | Q35930039 | ||
| Prognosis of amyotrophic lateral sclerosis with respiratory onset. | Q36143806 | ||
| Molecular biology of amyotrophic lateral sclerosis: insights from genetics | Q36573336 | ||
| A hundred years of Alzheimer's disease research | Q36610336 | ||
| The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease | Q36611426 | ||
| PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation | Q36794304 | ||
| Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease | Q36841500 | ||
| Screening of dementia genes by whole-exome sequencing in early-onset Alzheimer disease: input and lessons | Q37058503 | ||
| The gene coding for PGC-1alpha modifies age at onset in Huntington's Disease | Q37071213 | ||
| Genetics of amyotrophic lateral sclerosis: an update. | Q37153922 | ||
| Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. | Q37156193 | ||
| Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease | Q37156208 | ||
| Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden | Q37170658 | ||
| Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders | Q37199221 | ||
| Factors associated with HD CAG repeat instability in Huntington disease | Q37248874 | ||
| C9ORF72 intermediate repeat copies are a significant risk factor for Parkinson disease | Q37273743 | ||
| Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene | Q28245149 | ||
| Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2. | Q28262863 | ||
| The complex molecular biology of amyotrophic lateral sclerosis (ALS) | Q28263899 | ||
| The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease | Q28264134 | ||
| Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid | Q28279517 | ||
| Candidate gene for the chromosome 1 familial Alzheimer's disease locus | Q28295424 | ||
| Parkinson disease in twins: an etiologic study | Q28296110 | ||
| Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis | Q28303406 | ||
| Genetic variants in Alzheimer disease - molecular and brain network approaches | Q28596011 | ||
| A high-density genome-wide association screen of sporadic ALS in US veterans | Q28730882 | ||
| Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease | Q28742427 | ||
| Parkinson disease loci in the mid-western Amish | Q28943294 | ||
| Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis | Q28943310 | ||
| Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease | Q28943325 | ||
| Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data | Q28943361 | ||
| Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population | Q28943392 | ||
| Genomic determinants of motor and cognitive outcomes in Parkinson's disease | Q28943408 | ||
| Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease | Q28943440 | ||
| Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities | Q28943531 | ||
| ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study | Q28943532 | ||
| Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data | Q28943545 | ||
| Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. | Q29417029 | ||
| Genomewide association study for onset age in Parkinson disease | Q29417034 | ||
| Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21. | Q29417095 | ||
| Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database | Q29417106 | ||
| Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein | Q29547803 | ||
| Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease | Q29614879 | ||
| Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease | Q29614881 | ||
| Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases | Q29614910 | ||
| Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease | Q29614952 | ||
| Ageing and Parkinson's disease: substantia nigra regional selectivity | Q29615835 | ||
| El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis | Q29619074 | ||
| Amyotrophic lateral sclerosis | Q29619516 | ||
| Alzheimer's disease | Q30251865 | ||
| SORL1 is genetically associated with late-onset Alzheimer's disease in Japanese, Koreans and Caucasians | Q30420077 | ||
| CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. | Q30422005 | ||
| Genomewide association study for susceptibility genes contributing to familial Parkinson disease | Q30437480 | ||
| Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study | Q30439341 | ||
| Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans | Q30540165 | ||
| Identification of a novel Parkinson's disease locus via stratified genome-wide association study | Q30571934 | ||
| Identification of genetic modifiers of age-at-onset for familial Parkinson's disease | Q30833988 | ||
| Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease | Q30981327 | ||
| A genome-wide association study for late-onset Alzheimer's disease using DNA pooling | Q33372576 | ||
| An estimate of amyotrophic lateral sclerosis heritability using twin data. | Q33699565 | ||
| Identification of novel candidate genes for Alzheimer's disease by autozygosity mapping using genome wide SNP data | Q33753746 | ||
| Huntington's disease: from molecular pathogenesis to clinical treatment | Q33773061 | ||
| Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOE | Q33838241 | ||
| Linkage disequilibrium and association of MAPT H1 in Parkinson disease | Q33910188 | ||
| Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes | Q33991709 | ||
| Identifying modifier genes of monogenic disease: strategies and difficulties. | Q34025944 | ||
| C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis | Q34063137 | ||
| The link between the GBA gene and parkinsonism | Q34077492 | ||
| Juvenile onset Huntington's disease--clinical and research perspectives. | Q34091006 | ||
| Superoxide dismutases: role in redox signaling, vascular function, and diseases | Q34176532 | ||
| Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity | Q34201593 | ||
| Role of mendelian genes in "sporadic" Parkinson's disease | Q34240463 | ||
| A polymorphic DNA marker genetically linked to Huntington's disease | Q34255139 | ||
| Genome-wide analysis of genetic loci associated with Alzheimer disease | Q34339530 | ||
| Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews | Q34365028 | ||
| Mechanisms of MPTP toxicity and their implications for therapy of Parkinson's disease | Q34379001 | ||
| Multiple threshold model for the onset of Alzheimer's disease in the NAS-NRC twin panel | Q45110341 | ||
| Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes | Q45219801 | ||
| Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease | Q45290871 | ||
| CNR1 variation is associated with the age at onset in Huntington disease | Q45293518 | ||
| Reduced penetrance of the Huntington's disease mutation | Q45294302 | ||
| A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease. | Q45294471 | ||
| The S18Y polymorphism in the UCHL1 gene is a genetic modifier in Huntington's disease | Q45299526 | ||
| Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial | Q45300094 | ||
| Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results | Q45300364 | ||
| NR2A and NR2B receptor gene variations modify age at onset in Huntington disease in a sex-specific manner | Q45305405 | ||
| Correction of a pathogenic gene mutation in human embryos | Q45370513 | ||
| Genome-wide association analyses in Han Chinese identify two new susceptibility loci for amyotrophic lateral sclerosis | Q46876291 | ||
| Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. | Q46979432 | ||
| Genetics of neurodegenerative diseases: an overview | Q47189824 | ||
| Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease | Q47596541 | ||
| Beyond ALS and FTD: the phenotypic spectrum of TBK1 mutations includes PSP-like and cerebellar phenotypes | Q47596581 | ||
| Als and Ftd: Insights into the disease mechanisms and therapeutic targets | Q47652757 | ||
| Somatic and germline mosaicism in sporadic early-onset Alzheimer's disease | Q47679308 | ||
| A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci. | Q47823702 | ||
| Genome-wide association study of Parkinson's disease in East Asians | Q47844685 | ||
| Edaravone: A new drug approved for ALS. | Q47988417 | ||
| A Pooling Genome-Wide Association Study Combining a Pathway Analysis for Typical Sporadic Parkinson's Disease in the Han Population of Chinese Mainland | Q48077040 | ||
| A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease | Q48181387 | ||
| Transplantation of adrenal medullary tissue to striatum in parkinsonism. First clinical trials | Q48533464 | ||
| Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein | Q48634030 | ||
| Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease | Q48795523 | ||
| A genome-wide association study of sporadic ALS in a homogenous Irish population. | Q51899096 | ||
| Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives | Q37358932 | ||
| RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia | Q37409251 | ||
| Detection and interpretation of shared genetic influences on 42 human traits | Q37552665 | ||
| Genetic insights into sporadic Parkinson's disease pathogenesis | Q37583402 | ||
| Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans | Q37653312 | ||
| ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease | Q37716948 | ||
| Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis | Q37806860 | ||
| Mutations in GBA and risk of Parkinson's disease: a meta-analysis based on 25 case-control studies | Q38107046 | ||
| The role of heat shock proteins in Amyotrophic Lateral Sclerosis: The therapeutic potential of Arimoclomol | Q38131625 | ||
| Prakriti and its associations with metabolism, chronic diseases, and genotypes: Possibilities of new born screening and a lifetime of personalized prevention | Q38210536 | ||
| The prevalence of Parkinson's disease: a systematic review and meta-analysis | Q38224356 | ||
| Genetic modifiers of Huntington's disease | Q38243002 | ||
| EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans | Q38322311 | ||
| A genome-wide association study on amyotrophic lateral sclerosis in the Taiwanese Han population | Q38454596 | ||
| Next Generation Sequencing in Alzheimer's Disease | Q38559320 | ||
| Phenotypic spectrum of alpha-synuclein mutations: New insights from patients and cellular models | Q38581165 | ||
| Genetic Variants in SNCA and the Risk of Sporadic Parkinson's Disease and Clinical Outcomes: A Review | Q38637878 | ||
| Genomic insights into ayurvedic and western approaches to personalized medicine | Q38791078 | ||
| CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis | Q38805517 | ||
| SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorder | Q38837331 | ||
| Time Trends in the Incidence of Parkinson Disease | Q38870766 | ||
| The search for modifier genes in Huntington disease - Multifactorial aspects of a monogenic disorder | Q38897179 | ||
| Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia | Q38920843 | ||
| Genetics of early-onset Parkinson's disease in Finland: exome sequencing and genome-wide association study | Q38931515 | ||
| Investigation of next-generation sequencing technologies as a diagnostic tool for amyotrophic lateral sclerosis. | Q39058574 | ||
| Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R. | Q39079841 | ||
| Genome-wide gene-environment interaction analysis of pesticide exposure and risk of Parkinson's disease | Q39469472 | ||
| ASK1 and MAP2K6 as modifiers of age at onset in Huntington's disease. | Q40004660 | ||
| Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis | Q40143586 | ||
| Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease | Q40849918 | ||
| A genome-wide association study of late-onset Alzheimer's disease in a Japanese population. | Q40863191 | ||
| Occurrence of Parkinson's syndrome in type I Gaucher disease | Q41211077 | ||
| Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis | Q41392222 | ||
| Levodopa-induced Dyskinesia: Clinical Features, Pathophysiology, and Medical Management | Q41626118 | ||
| Huntington's disease: the case for genetic modifiers | Q42181050 | ||
| Association study of Parkin gene polymorphisms with idiopathic Parkinson disease | Q42604036 | ||
| Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit | Q43049762 | ||
| The hOGG1 Ser326Cys polymorphism and Huntington's disease. | Q43254772 | ||
| An outcome study of riluzole in amyotrophic lateral sclerosis--a population-based study in Ireland, 1996-2000. | Q44407280 | ||
| Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population | Q44428663 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurodegeneration | Q1755122 |
| P304 | page(s) | 625-648 | |
| P577 | publication date | 2018-07-01 | |
| P1433 | published in | Journal of Genetics | Q975661 |
| P1476 | title | Advances in the discovery of genetic risk factors for complex forms of neurodegenerative disorders: contemporary approaches, success, challenges and prospects | |
| P478 | volume | 97 |
| Q104139660 | Establishment of FXS-A9 panel with a single human X chromosome from Fragile X syndrome-associated individual |
| Q91638254 | Neonatal Brain Injury and Genetic Causes of Adult-Onset Neurodegenerative Disease in Mice Interact With Effects on Acute and Late Outcomes |
Search more.